ADIL vs WY · $6.0M cap vs P/E 43, rev $3.59B
Adial Pharmaceuticals Inc (ADIL) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
ADIL does not have a complete income-statement cache yet.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
ADIL currently screens at market cap $6.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the ADIL and WY stock pages for the full models.
Not investment advice.